日本肝臓学会

▶️Efficacy and Safety of Atezolizumab Plus Bevacizumab Versus Durvalumab Plus Tremelimumab for Unresectable Hepatocellular Carcinoma in Patients With Child–Pugh Class B: A Real-World Study 👉doi.org/10.1111/hepr.7… #LiverX @WileyHealth

▶️Post-COVID-19 Changes in Body Composition and Adiposity in Patients With Chronic Liver Disease: A Longitudinal Study From Japan 👉doi.org/10.1111/hepr.7… #LiverX @WileyHealth

【School of Hepatology in Yokohama 開催のお知らせ🧑‍🎓】 2026/10/11-12に日本肝臓学会@JSHLiverの若手の先生向け研修会を開催します！ テーマは『 #代謝機能障害関連脂肪性肝疾患（#MASLD）を究める』です。 締め切りは7/31です。 皆様の応募をお待ちしております🎉🎉🎉jsh.or.jp/medical/news/a…

【学会誌】日本肝臓学会和文誌「肝臓」5月号が発刊されました📖 👉jstage.jst.go.jp/browse/kanzo/6… ▶️肝硬変におけるアンモニアの臨床的意義～静脈血アンモニア濃度は，肝性脳症，特に不顕性肝性脳症の病態を正確に反映しているか？～ 👉doi.org/10.2957/kanzo.… ▶️地域コホートにおけるアンケート調査を用いた新規HCV拾い上げ戦略 👉doi.org/10.2957/kanzo.… ▶️郵送通知による肝炎ウイルス検査陽性者の医療再接続支援とマイクロエリミネーションへの展開 👉doi.org/10.2957/kanzo.… ▶️乳癌治療薬アベマシクリブによるdrug-induced autoimmune-like hepatitisが疑われた1例 👉doi.org/10.2957/kanzo.… ▶️アテゾリズマブ＋ベバシズマブ併用療法中に多発関節炎および高ビリルビン血症を呈し，ステロイド治療が奏効した肝細胞癌の一例 👉doi.org/10.2957/kanzo.… ▶️腹膜炎に続発し肝外からの炎症波及により発症，治療に難渋した肝炎症性偽腫瘍の一例―NSAIDsの治療的可能性を契機とした経過を通して― 👉doi.org/10.2957/kanzo.… ▶️超高齢者に発症したリスク因子陰性・非肝硬変性肝細胞癌の1例 👉doi.org/10.2957/kanzo.… ▶️免疫チェックポイント阻害薬投与後に出現し，免疫関連有害事象との鑑別が困難であったC型慢性肝炎の急性増悪の一例 👉doi.org/10.2957/kanzo.… ▶️愛媛県中予地区におけるB型肝炎ウイルスキャリアの遺伝子型の現状 👉doi.org/10.2957/kanzo.… ▶️一次医療におけるFIB-4 indexの年齢依存性と高齢者での高値判定増加―地域一次医療における118,556例の横断解析― 👉doi.org/10.2957/kanzo.…

▶️Animal Naming Test Can Identify Covert Hepatic Encephalopathy in Patients With Cirrhosis With Limited Influence From Age or Educational Level 👉doi.org/10.1111/hepr.7… #LiverX @WileyHealth

#SpecialReport ▶️Liver Transplantation in Japan: Registry by the Japanese Liver Transplantation Society 👉doi.org/10.1111/hepr.7… #LiverX @WileyHealth

#Review ▶️The Microbiome-Gut-Liver Axis Drives Post-Kasai Fibrosis in Biliary Atresia: From Mechanism to Precision Intervention 👉doi.org/10.1111/hepr.7… #LiverX @WileyHealth

#Editorial ▶️Endoscopic Variceal Therapy and Transitional Care in Pediatric Portal Hypertension: A Review With a Focus on Long-Term Outcomes and Adherence 👉doi.org/10.1111/hepr.7… #LiverX @WileyHealth

#Editorial ▶️Dual Escape From Ferroptosis and Disulfidptosis Denotes a Hypermetabolic, High-Risk Subtype of Hepatocellular Carcinoma 👉doi.org/10.1111/hepr.7… #LiverX @WileyHealth

#Editorial ▶️Platelets as Context-Dependent Modulators of Hepatic Microvascular Injury in Metabolic Dysfunction–Associated Steatotic Liver Disease 👉doi.org/10.1111/hepr.7… #LiverX @WileyHealth

Our May issue is out!! 👉onlinelibrary.wiley.com/toc/1872034x/2… #LiverX @WileyHealth

#LiverCancer ▶️The Low Platelet Count at the Start of Atezo + Bev Therapy for Unresectable Hepatocellular Carcinoma Predicts Deteriorated Liver Function at the Time of Disease Progression Thereafter: A Multicenter Analysis 👉doi.org/10.1111/hepr.7… #LiverX @WileyHealth

#LiverCancer ▶️Clinical Impact of Recurrence Beyond the Milan Criteria After Curative Resection of Hepatocellular Carcinoma 👉doi.org/10.1111/hepr.7… #LiverX @WileyHealth

#LiverCancer ▶️Clinical Outcomes of Reduced-Dose Cabozantinib as Third- or Later-Line Therapy After Immune Checkpoint Inhibitors in Advanced Hepatocellular Carcinoma: A Real-World Study 👉doi.org/10.1111/hepr.7… #LiverX @WileyHealth

#LiverCancer ▶️Lymphocyte–Monocyte Ratio Predicts Survival in Patients With Unresectable Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab: A Multicenter Analysis 👉doi.org/10.1111/hepr.7… #LiverX @WileyHealth

#Cirrhosis ▶️Clinical Utility of the aMAP Risk Score for Predicting the Recurrence of Hepatic Encephalopathy After Rifaximin Treatment in Patients With Liver Cirrhosis: A Retrospective Cohort Study 👉doi.org/10.1111/hepr.7… #LiverX @WileyHealth

#Cirrhosis ▶️Soluble Cluster of Differentiation 14 as a Prognostic Marker in Decompensated Cirrhosis With Water Retention 👉doi.org/10.1111/hepr.7… #LiverX @WileyHealth

#Fibrosis ▶️Metabolic Effect on Serum Mac-2 Binding Protein Glycan Isomer Level and Its Normal Range in the Health Checkup Examinee 👉doi.org/10.1111/hepr.7… #LiverX @WileyHealth

#Fibrosis ▶️Digital Polymerase Chain Reaction-Based Fecal Streptococcus Quantification for Liver Fibrosis Assessment in Chronic Liver Disease 👉doi.org/10.1111/hepr.7… #LiverX @WileyHealth

#AutoimmuneDisease ▶️A Pharmacovigilance Study of Immune Checkpoint Inhibitor-Associated Cholangitis: Insights From the FDA Adverse Event Reporting System 👉doi.org/10.1111/hepr.7… #LiverX @WileyHealth